Nabriva
formerly Nabriva TherapeuticsVienna, Austria · Founded 2005 · $142.0M raised
- Headquarters
- Vienna
- Founded
- 2005
- Business Model
- B2B
- Website
- nabriva.com
- Total Funding
- $142.0M
- Last Round
- $120.0M Series BApr 2015
- Rounds
- 2
About
A commercial-stage biopharmaceutical company developing novel antibiotics to treat serious infections.
Summary
Nabriva is a Biotech company based in Vienna, Austria, founded in 2005. It has raised $142.0M in total across 2 rounds, most recently a $120.0M Series B round in Apr 2015. Investors include Vivo Capital, OrbiMed and Novartis Venture Fund.
Funding History
Apr 2015
Sign up to see all 2 rounds
Venture Round through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nabriva"><img src="https://indexed.vc/api/badge/company/nabriva" alt="Nabriva on Indexed.vc" width="260" height="76" /></a>